GSK

  • David Willetts, Universities and Science Minister, during a recent visit to the GlaxoSmithKline.

    GSK’s Commitment to Transparency by Opening Up Their Data

    October 12, 2012 | By: | In: News

    GlaxoSmithKline has announced plans to be more open about its clinical trial data, be more transparent to the public and actively collaborate with scientists and firms outside GSK to find new drugs to treat the diseases plaguing the world, from novel antibiotics to cures for malaria and tuberculosis.

Ad

STAY CONNECTED

 
Ad